News
11-16-2010, 06:10 AM
Red-blood-cell-boosting drugs used to treat anemia may undermine breast cancer treatment with Herceptin, a targeted therapy that blocks the cancer-promoting HER2 protein, researchers from The University of Texas MD Anderson Cancer Center report in the Nov. 16 edition of Cancer Cell...
More... (http://mnt.to/f/3MD3)
More... (http://mnt.to/f/3MD3)